Skip to main content
SpringerLink
Log in

Medikamentöse Schmerztherapie in der Onkologie

  • Chapter
Die Onkologie

  • 341 Accesses

Zusammenfassung

Wie bei keiner anderen Krankheit wird bei Tumorpatienten der Schmerz zum Signal des unaufhaltsamen Fortschreitens der lebensbedrohenden Erkrankung und zählt zu den häufigsten und am meisten gefürchteten Symptomen (Bonica 1985; Coyle et al. 1990). Zahlreiche Übersichtsarbeiten haben gezeigt, dass 30–50% der Patienten bei Diagnosestellung und 60–90% der Patienten mit fortgeschrittener Tumorerkrankung an Dauerschmerzen leiden (Daut et al.1982; Foley 1979; Levin et al.1985;Twycross et al.1982; World Health Organization 1996).

The erratum of this chapter is available at http://dx.doi.org/10.1007/978-3-662-06670-6_82

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Ahmedzai S, Brooks D (1997) Transdermal Fentanyl versus sustained-release oral morphine in cancer pain: Preference, efficacy, and quality of Iife. J Pain Sympt Manage 5: 254–261

    Google Scholar 

  • American College of Physicians Health and Public Committee (1983) Drug therapy for severe chronic pain in terminal illness.Ann Intern Med 99: 870

    Google Scholar 

  • Angarola RT,Wray SD (1989) Legal impediments to cancer pain treatment. In: Hill CS, Fields WS (eds) Advances in pain research and therapy, vol 11. Raven Press, New York, p 213

    Google Scholar 

  • Bach V, Kamp-Jensen M, Jensen N-H, Eriksen J (1991) Buprenorphine and sustained release morphine–effect and side-effects in chronic use. Pain Clinic 4: 87–93

    Google Scholar 

  • Bailey PL, Stanley TH (1994) Intravenous opioid Anesthetics. In: Miller RD (ed) Anesthesia, 4th edn. Churchill Livingstone, New York, pp 291–387

    Google Scholar 

  • Bajwa ZH.Borsook D (1996) The pain management imperative. In: Borsook D, LeBel AA, McPeek B (eds) The Massachusetts General Hospital handbook of pain management. Little, Brown and Company, Boston New York Toronto London Little, pp 3–7

    Google Scholar 

  • Beaver WT (1988) Impact of non-narcotic analgesics on pain management. Am J Med 84: 3–15

    PubMed  CAS  Google Scholar 

  • Berina LF, Guernsey BG, Hokanson JA, Doutre WH, Fuller LE (1985) Physician perception of a triplicate prescription law. Am J Hosp Pharm 42: 857

    CAS  Google Scholar 

  • Berkowitz BA, Ngai SH,Yang JC (1975) The disposition of morphine in surgical patients. Clin Pharmacol Ther 17: 629–635

    CAS  Google Scholar 

  • Bonica JJ (1977) Neurophysiologic and pathologic aspects of acute and chronic pain. Arch Surg 112: 750–761

    PubMed  CAS  Google Scholar 

  • Bonica JJ (1979) Important clinical aspects of acute and chronic pain. In: Mechanisms of pain and analgesic compounds.ln: Beers RF, Bassett EG (eds) Raven Press, New York, pp 15–29

    Google Scholar 

  • Bonica JJ (1985) Treatment of cancer pain: current status and future need. In:Fields HL, Dubner R,Cervero R (eds) Advances in pain research and therapy, vol 9. Raven Press, New York, pp 617–628

    Google Scholar 

  • Bonica JJ (1990) Cancer pain.ln:Bonica JJ (ed)The management of pain. Lea Febiger, Philadelphia, p 400

    Google Scholar 

  • Breitbart W, Holland JC (1988) Psychiatric complications of cancer. Curr Ther Hematol Oncol 3: 268

    Google Scholar 

  • Bruera E, Roca E,Cedaro L,Carrao S,Chacon R (1985) Action of oral methylprednisolone in terminal cancer patients: a prospective randomized double blind study. Cancer Treat Rep 69: 751–754

    CAS  Google Scholar 

  • Bruera E, Fainsinger R, Spachynski K (1995) Clinical efficacy and safety of a novel controlled release morphine suppository and subcutaneous morphine in cancer pain: a randomized evaluation. J Clin Oncol 13: 1520–1527

    PubMed  CAS  Google Scholar 

  • Brune K, Beck WS (1993) Nichtopioidanalgetika. In: Zenz M, Jurna I (Hrsg) Lehrbuch der Schmerztherapie. Wissenschaftliche Verlagsgesellschaft,Stuttgart,S 121–136

    Google Scholar 

  • Campora E, Merlini L, Pace M, Bruzzone M, Luzzani M, Gottlieb A, Rosso R (1991) The incidence of narcotic induced emesis. J Pain Symptom Manage 6: 428–430

    PubMed  CAS  Google Scholar 

  • Cherny NI, Portenoy RK, Raber M, Zenz M (1994) Medikamentöse Therapie von Tumorschmerzen. Eigenschaften von Nichtopioiden und Opioiden. Schmerz 8: 195–209

    PubMed  CAS  Google Scholar 

  • Cherny NI, Portenoy RK, Raber M, Zenz M (1995) Medikamentöse Therapie von Tumorschmerzen.Teil Ill: Adjuvantien. Schmerz 9: 55–69

    PubMed  CAS  Google Scholar 

  • Cleeland CS, Gonin R, Hatfield AK, Edmonson JH, Blum RH, Stewart JA, Pandya IO (1994) Pain and its treatment in outpatients with metastatic cancer. N Engl J Med 330: 592–596

    PubMed  CAS  Google Scholar 

  • Cleeland CS, Cleeland LM, Dar R, Rinehardt LC (1986) Factors influencing physican management of cancer pain. Cancer 58: 796–800

    PubMed  CAS  Google Scholar 

  • Cooper K, Bennet W (1987) Nephrotoxicity of common drugs used in clinical practice. Arch Intern Med 147: 1213–1218

    PubMed  CAS  Google Scholar 

  • Coyle N,AdelhardtJ,Foley KM, Portenoy RK (1990) Character of terminal illness in the advanced cancer patient:pain and other symptoms during the last four weeks of life.J Pain Symptom Manage 5: 83–93

    Google Scholar 

  • Dar R, Beach C, Barden P, Cleeland CS (1992) Cancer pain in the marital system: a study of patients and spouses. J Pain Symptom Manage 7: 87–93

    PubMed  CAS  Google Scholar 

  • Daut RL, Cleeland CS (1982) The prevalence and severity of pain in cancer. Cancer 50: 1913–1918

    PubMed  CAS  Google Scholar 

  • DeConno, Ripamonti C, Saita L (1995) The role of the rectal route in treating cancer pain: a randomized crossover clinical trial of oral vs. rectal morphine administration of opioid-naive cancer patients with pain.J Clin Oncol 13: 1004–1008

    CAS  Google Scholar 

  • Devor M, Govrin-lippman R, Raber P (1985) Corticosteroids reduce neuro-ma hyperexcitability. In: Fields HL, Dubner R, Crevero F (eds) Proceedings of the Fourth World Congress on Pain. Advances in pain research and therapy, vol 9. Raven Press, New York, p 451

    Google Scholar 

  • Dittrich C (1996) Strategie der Schmerztherapie/Schmerzkontrolle bei Patienten mit Malignomen. Hausarzt 6: 6–13

    Google Scholar 

  • Doyle D (1991) Morphin: myths, morality and economics. Postgrad Med J 67 [Suppl 21: 70

    Google Scholar 

  • Elliot F, Little A,Milbrandt W (1976) Carbamazepine for phantom limb phenomena. N Engl J Med 295: 678

    Google Scholar 

  • Elliott TE, Murray DM, Oken MM, Johnson KM, Braun BL, Elliott BA, Post-White J (1997) Improving cancer pain mangement in communities: main results from a randomized controlled trial.J Pain Symptom Manage 13: 191–203

    CAS  Google Scholar 

  • Fainsinger R, Schoeller T, Bruera E (1993) Methadone in the management of cancer pain:a review. Pain 52: 137–147

    PubMed  CAS  Google Scholar 

  • Fazeny B, Huber H (2000) Der Wunsch nach assistiertem Selbstmord bei unheilbaren Krebspatienten–Eine Standortbestimmung der Hauptursachen für die zunehmenden Diskussionen. In: Bonelli J, Prat EH (Hrsg) Leben–Sterben–Euthanasie? Springer, Wien New York, pp 97–102

    Google Scholar 

  • Fazeny B, Muhm M, Hauser I et al. (2000) Barriers in cancer pain management. Wien Klin Wochenschr 112: 987–981

    Google Scholar 

  • Fazeny B, Muhm M, Berzlanovich A, Wenzel C, Hagmeister H, Marosi Ch (2000) Schmerztherapie im Lichte rezenter Gesetzesnovellierungen und deren praktische Konsequenzen. Wien Klin Wochenschr 112: 372–375

    PubMed  CAS  Google Scholar 

  • Foldes FF, Sverdlow M, Siker ES (1964) Narcotics and Narcotic Antagonists. Charles C Thomas, Springfield, IL

    Google Scholar 

  • Foley KM (1979) Pain syndromes in patients with cancer. In: Bonica JJ, Ventafridda V (eds) Advances in pain research and therapy. Raven Press, New York, pp 59–75

    Google Scholar 

  • Foley KM (1985) The treatment of cancer pain. N Engl J Med 313: 84–95

    PubMed  CAS  Google Scholar 

  • Foley KM (1991) Clinical tolerance to opioids. In: Basbaum AI, Bessom JM (eds) Towards a new pharmacotherapy of pain, Dahlem Konferenzen. John Wiley Sons,Chinchester, p 181

    Google Scholar 

  • Foley KM (1993) Management of cancer pain. In: DeVita VT Jr, Hellman S, Rosenberg SA (eds) Cancer: Principles Practice ofOncology,4th edn. JB Lippincott, Philadelphia, pp 2417–2448

    Google Scholar 

  • Foley KM (1996) Pain relief into practice:rhetoric without reform.J Clin On-col 13: 2149–2151

    Google Scholar 

  • Foley KM, Inturrisi CE (1987) Analgesic drug therapy in cancer pain: Principles and practice. Med Clin North Am 72: 207–232

    Google Scholar 

  • Forth W, Henschler D, Rummel W, Starke K (1992) Pharmakologie und Toxikologie. B. I. Wissenschaftsverlag, Mannheim

    Google Scholar 

  • Fromm GH (1989)Trigeminal neuralgia and related disorders. In: Portenoy RK (ed) Pain:Mechanisms and syndromes. Neruologic clinics,vol 7. WB Saunders, Philadelphia, p 305

    Google Scholar 

  • Gonzales GR, Elliott KJ, Portenoy RK, Foley KM (1991) Impact of a comprehensive evaluation in the management of cancer pain. Pain 47: 141–144

    PubMed  CAS  Google Scholar 

  • Green WR, David WH (1991) Titrated intravenous barbiturates in the control of symptoms in patients with terminal cancer. South Med J 84: 332–337

    Google Scholar 

  • Grond S, Zech D, Dahlmann H, Schug SA, Stobbe B, Lehmann KA (1990) Uberweisungsgrund:,,therapieresistente“ Tumorschmerzen. Analyse der Schmerzmechanismen und der medikamentösen Vorbehand1 u ng. Schmerz 4: 193–200

    PubMed  CAS  Google Scholar 

  • Hanks GW,Twycross RG (1984) Pain, the physiological antagonist of opioid analgesics. Lancet 1: 1477–1478

    Google Scholar 

  • Hanks GW, Justins D (1992) Cancer pain: management. Lancet 339: 1031–1036

    PubMed  CAS  Google Scholar 

  • Hanks GW,Twycross RG, Lloyd JW (1981) Unexpected complication of successful nerveblock. Anaesthesia 36: 37–39

    Google Scholar 

  • Hanks GW,Trueman T,Twycross RG (1983) Corticoids in terminal cancer. Postgrad Med J 59: 702

    Google Scholar 

  • Hayward J (1979) Psychological and social aspects of pain. Nursing 1: 1–7

    Google Scholar 

  • Hodes R (1989) Cancer patients’ needs and concerns when using narcotic analgesics. In: Hill CS, Fields WS (eds) Advances in pain research and therapy, vol 11. Raven Press, New York, pp 91–94

    Google Scholar 

  • Houde RW (1982) Methods for measuring clinical pain in humans. Acta Anesthesiol Scand [Suppl] 74: 25–20

    CAS  Google Scholar 

  • Hsieh JC, Carr D (1996) Choosing a therapeutic approach: opioids. In: Borsook D, LeBel AA, McPeek B (eds) The Massachusetts General Hospital handbook of pain management. Little, Brown and Company, Boston New York Toronto London pp 47–75

    Google Scholar 

  • Insel PA (1990) Analgesic antipyretics and antiinflammatory agents. Drugs employed in the treatment of rheumatic arthritis and gout. In: Gillan AG, RaIITW,Teylor P (eds) The pharmacologic basis oftherapeutics,8th edn. Pergamon Press, New York, p 638

    Google Scholar 

  • Inturrisi CE (1989) Management of cancer pain. Cancer 63: 2308–2320

    PubMed  CAS  Google Scholar 

  • Jacox A, Carr DB, Payne R (1994) New clinical-practice guidelines for the management of pain in patients with cancer. N Engl J Med 330: 651–655

    PubMed  CAS  Google Scholar 

  • Jaffe JH, Martin WR (1990) Opioid analgesics and antagonists. In: Gillamn AG, Rall TW, Nies AS,Teylor P (eds) The pharmacological basis of therapeutics, 8th edn. Pergamon Press, New York, p 485

    Google Scholar 

  • Jage J (1990) Morphin-Mythos - Ausführungen zur Opiat-Analgesie. Med Welt 41: 92

    Google Scholar 

  • Jaksch W (1 996) Analgetika bei akuten Schmerzen. pm-Verlag, Kössen

    Google Scholar 

  • Jurna I, Motsch J (1993a) Nichtanalgetika: Antidepressiva, Antikonvulsiva, Neuroleptika, Tranquilanzien und zentrale Muskelrelaxanzien, Clonidin,Cortison.In:Zenz M,Jurna I (Hrsg) Lehrbuch der Schmerztherapie. Wissenschaftliche Verlagsgesellschaft, Stuttgart, S 155–165

    Google Scholar 

  • Jurna I, BaldaufJ (1993b) Retardiert freigesetztes Naloxon oral:Aufhebung der Obstipation durch orales Morphin ohne Beseitigung der Analgesie.Schmerz 7: 314–321

    CAS  Google Scholar 

  • Jurna I, Spohrer B, Bock R (1992) Intrathecal injection of salicylic acid. Salicylic acid and indomethacine depress c-fibre evoked activity in the rat thalamus and spinal cord. Pain 49: 249–255

    PubMed  CAS  Google Scholar 

  • Kanner RM, Foley KM (1981) Patterns of narcotic drug use in a cancer pain clinic. Ann NY Acad Sci 362: 161–172

    PubMed  CAS  Google Scholar 

  • Kaufman PN, Krevsky B,Malmud LS, Maurer AH, Somers MB, Siegel JA, Fisher RS (1988) Role of opiate receptors in the regulation of colonic transit. Gastroenterology 94: 1351–1356

    CAS  Google Scholar 

  • Kloke M (1995) Therapie chronischer Tumorschmerzen. In: Therapiekonzepte Onkologie.Seeber S, Schütte J (Hrsg) Springer, Berlin Heidelberg NewYork,Tokyo,S 1092–1113

    Google Scholar 

  • Kloke M, Höffken K, Olbrich H, Schmidt CG (1991) Antidepressants and anticonvulsants for the treatment of neuropathic pain-syndromes in cancer patients. Oncology 14: 40–43

    CAS  Google Scholar 

  • Kuhar MJ, Pert CB, Snyder SH (1973) Regional distribution of opiate receptor binding in monkey and human brain. Nature 245: 447–450

    PubMed  CAS  Google Scholar 

  • Leiberman A (1977) Use of high-dose corticosteroids in patients with inoperable brain tumors.J Neurol Neurosurg Psychiatry 40: 678

    Google Scholar 

  • Levin D, Cleeland CS, Dar R (1985) Public attitudes toward cancer pain.Cancer 56: 2337–2339

    CAS  Google Scholar 

  • Lindena G, Müller S, Zenz T (1994) Opioidverschreibung durch niedergelassene Ärzte. Schmerz 8: 228–234

    PubMed  CAS  Google Scholar 

  • Ling GSFF, Spiegel K, Lockhart SH, Pasternak GW (1985) Separation of opioid analgesia from respiratory depression: evidence for different receptor mechanism.J Pharmacol Exp Ther 232: 149–155

    CAS  Google Scholar 

  • Martin WR, Eades CG, Thompson JA (1976) The effects of morphine- and nalorphine-like drugs in the nondependent and morphine-dependent chronic spinal dog.J Pharmacol Exp Ther 197: 517–532

    CAS  Google Scholar 

  • McCaffery M (1983) Nursing the patient in pain. Harper and Row, London

    Google Scholar 

  • Mc Quay HJ, Carroll D, Faura CC, Gavaghan DJ, Hand CW, Moore RA (1990) Oral morphine in cancer pain: influences on morphine and metabolite concentration. Clin Pharmacol Ther 48: 236–244

    PubMed  CAS  Google Scholar 

  • Melzack R (1986) Neurophysiological foundations of pain. In: Sternbach RA:The Psychology of Pain. Raven Press, New York, pp 1–24

    Google Scholar 

  • Mercadante S,Agnello A,Armata MG, Pumo S (1997)The inappropriate use of the epidural route in cancer pain. J Pain Symptom Manage 13: 233–237

    Google Scholar 

  • Miller R (1986) Midazolam as an adjunct to meperidine analgesia for postoperative pain.Clin J Pain 2: 37

    Google Scholar 

  • Moulin DE, Foley KM (1990) A review of a hospital-based pain service.In:Foley KM, Bonica JJ, Ventafridda V (eds) Advances in pain research and therapy. Raven Press, New York, pp 413–428

    Google Scholar 

  • O’Rourke K (1992) Pain Relief:The perspective of Catholic Tradition. J Pain Symptom Manage 7: 485–491

    PubMed  Google Scholar 

  • Paul D, Standifier KM, Inturrisi CE, Pasternak GW (1989) Pharmacological characterization of morphine-6-glucuronide,a very potent morphine metabolite.J Pharmacol ExpTher 251: 477–483

    CAS  Google Scholar 

  • Paul D, Pick CG,Tive LA, Pasternak GW (1991) Pharmacological characterization of nalorphine, a kappa3 analgesic. J Pharmacol Exp Ther 257: 1–7

    CAS  Google Scholar 

  • Pert CB, Snyder SH (1973) Opiate receptor: demonstration in nervous tissue.Science 179: 1011

    CAS  Google Scholar 

  • Piletta P, Porchet HC, Dayer P (1991) Central analgesic effect of acetaminophene but not of aspirin. Clin Pharm Ther 49: 350–354

    CAS  Google Scholar 

  • Portenoy RK (1993) Cancer pain management. Sem Oncol 2 [Suppl 1]: 19–35

    Google Scholar 

  • Portenoy RK, Moulin DE, Rogers A, Inturrisi CE, Foley KM (1985) Intravenous infusion of opioids in cancer pain: Clinical review and guidelines for use. Cancer Treat Rep 70: 575–581

    Google Scholar 

  • Portenoy RK, Foley KM, Stulman J (1991) Plasma morphine and morphine6-glucuronide during chronic morphine therapy for cancer pain: Plasma profiles, steady-state concentrations and the consequences of renal failure. Pain 47: 13–19

    PubMed  CAS  Google Scholar 

  • Portenoy RK,Thaler HT, Inturrisi CE, Friedlander-Klar H, Foley KM (1992) The metabolite, morphine-6-glucuronide, contributes to the analgesia produced by morphine infusion in pain patients with normal renal function. Clin Pharmacol Therap 51: 422–431

    Google Scholar 

  • Principles of analgesic use in the treatment of acute pain and chronic cancer pain (1989) A concise guide to medical practice.2nd ed.Skokie, III.: American Pa in Society

    Google Scholar 

  • Ripamonti C,Bruera E (1991) Rectal, buccal,and sublingual narcotics for the management of cancer pain.J Palliat Care 7: 30–35

    Google Scholar 

  • Rogers M, Cerda JJ (1989) The narcotic bowel syndrome. J Clin Gastroenterol 11: 132–135

    PubMed  CAS  Google Scholar 

  • Roy D (1990) Need they sleep before they die. J Palliat Care 6: 3–4

    Google Scholar 

  • Seff LB, Cuccherini BA, Zimmermann HI, Adler E, Benjamin SB (1986) Acetaminophene hepatotoxicity in alcoholics. Ann Int Medicine 104: 399–404

    Google Scholar 

  • Simon EJ, Hiller JM, Edelman I (1973) Stereospecific binding of the potent narcotic analgesic [3H]-etorphine to rat-brain homogenate. Proc Natl Acad Sci US 70: 1947–1949

    CAS  Google Scholar 

  • Singh PN, Sharma P, Gupta PK, Panday K (1981) Clinical evaluation of diazepam for relief of postoperative pain. Br J Anesth 53: 831

    CAS  Google Scholar 

  • Sorge J, Lüders B, Werry C, Pichlmayr I (1996) Die Versorgung von ambulanten Tumorpatienten mit Opioidanalgetika. Schmerz 10: 283–291

    PubMed  CAS  Google Scholar 

  • Stein C (1993) Peripheral mechanisms ofopioid analgesia.Anesth Analg 76: 182–191

    CAS  Google Scholar 

  • Sunshine A, Olson NZ (1988) Analgesic efficacy of ketoprofene in postpartum, general surgery and chronic cancer pain. J Clin Pharmacol 28: 47–54

    Google Scholar 

  • Sverdlow M,Cundill JG (1981) Anticonvulsant drugs used in the treatment of lancinating pain. A comparison. Anesthesia 36: 1129

    Google Scholar 

  • Sykes NP (1991) Oral naloxone in opioid-associated constipation. Lancet II: 1475

    Google Scholar 

  • Tannock I, Gospdarowicz M, Meakin W, Panzarella T, Stewart L, Rider W (1989) Treatment of metastatic prostatic cancer with low-dose prednisone:evaluation of pain and quality of life as pragmatic indices of response.J Clin Oncol 7: 590

    CAS  Google Scholar 

  • Terenius L (1973) Characteristics of the„receptor“for narcotic analgesics in synaptic plasma membrane fractions from rat brain. Acta Pharmacol Toxicol Kopenh 33: 377–384

    CAS  Google Scholar 

  • Twycross RG (1974) Clinical experience with diamorphine in advanced malignant disease. Int J Pharmacol Therap Toxicol 9: 184–198

    Google Scholar 

  • Twycross RG (1984) Relief of pain. In: Saunders C (ed) The Management of Terminal Malignant Disease. Edward Arnold, London, pp 64–90

    Google Scholar 

  • Twycross RG (1995) Therapeutics in terminal cancer, 3rd edn. RadcliffeMedical Press, Oxford

    Google Scholar 

  • Twycross RG, Ventafridda V (1979) Non-narcotic corticosteroid and psychotropic drugs in the continuing care of terminal cancer patients. In: Proceedings of an international seminar on continuing care of terminal cancer patients. Pergamon Press, New York

    Google Scholar 

  • Twycross RG, Fairfield S (1982) Pain in far-advanced cancer. Pain 14: 303–310

    PubMed  CAS  Google Scholar 

  • Twycross RG, Lack SA (1983) Pain–a broader concept. In: Symptom Control in far advanced cancer. Pitman, London, pp 49–55

    Google Scholar 

  • Twycross RG (1998) Opioid analgesics in cancer pain:current practice and controversies. Cancer Surveys 7: 29–51

    Google Scholar 

  • Ulsenheimer K (1999) Arzt und Drogenwesen. In: Laufs A, Uhlenbruck W (Hrsg) Handbuch des Arztrechts.C.H. Beck, München 1079–1084

    Google Scholar 

  • Van Holten-Verzantvoort ATM,Zwinderman AH,Aaronson RK (1991)The effect of supportive pamidronate treatment on aspects of quality of life of patients with advanced breast cancer. Eur J Cancer 27:544–549

    Google Scholar 

  • Ventafridda V, Fochi C, DeConno F, Sganzerla E (1980) Use of NSAIDs in the treatment of pain in cancer. Br J Clin Pharmacol 10: 343–346

    Google Scholar 

  • Ventafridda V,Tamburini M, DeConno F (1985) Comprehensive treatment of cancer pain.ln:Fields HL,Dubner R,Cervero F (eds) Advances in pain research and therapy. Raven Press, New York, pp 617–628

    Google Scholar 

  • Ventafridda V,Tamburini M,Caraceni A, DeConno F, Naldi F (1987) A validation study of the WHO method for cancer pain relief. Cancer 59: 850–856

    Google Scholar 

  • VentafriddaV,Bianchi M, Ripamonti C,Sacerdote P,DeConno F,Zecca R,Paneari AE (1990a) Studies on the effects of antidepressant drugs on the antinoceptive action of morphine and on plasma morphine in rat and man. Pain 43: 155–162

    Google Scholar 

  • Ventafridda V, Ripamonti C, DeConno F, Tamburini M (1990b) Symptom prevalence and control during cancer patients’ last days of life. J Palli-at Care 6: 7–11

    CAS  Google Scholar 

  • Wallenstein SL (1975) Analgesic studies of aspirin in cancer patients. Proceedings of the aspirin symposium. Aspirin Foundation, London, p 5

    Google Scholar 

  • Walsh SL, Preston KL, Stitzer ML, Cone EJ, Bigelow GE (1994) Clinical pharmacology of buprenorphine: Ceiling effects at high doses. Clin Pharmacol Ther 55: 569–580

    PubMed  CAS  Google Scholar 

  • Walsh TD (1990) Prevention of opioid side effects.J Pain Symptom Manage 5: 362–367

    CAS  Google Scholar 

  • Ward SE, Goldberg N, Miller-McCauley V et al. (1993) Patient-related barriers to management of cancer pain. Pain 52: 319–324

    PubMed  CAS  Google Scholar 

  • Watanabe S, Belize M, Kuehn N (1996) Capsules and suppositories of methadone for patients on high-dose opioids for cancer pain. Clinical and economic considerations.Cancer Treat Rev 22: 131–136

    CAS  Google Scholar 

  • Waugh L (1988) Psychological aspects of cancer pain. Professional Nurse 9: 504–508

    Google Scholar 

  • Weissman DE (1988) Glucosteroid therapy for brain metastases and epidural spinal cord compression:a review.J Clin Oncol 6: 543

    CAS  Google Scholar 

  • Weissman DE (1996) Cancer pain education for physicians in practice: es- tablishing a new paradigm.J Pain Symptom Manage 12: 364–371

    CAS  Google Scholar 

  • Weissman DE, Dahl JL (1990) Attitudes about cancer pain: a survey of Wisconsin’s first-year medical students. J Pain Symptom Manage 5: 345–349

    PubMed  CAS  Google Scholar 

  • Willer IC, DeBrouckertT, Bussel B, Robi-Brauni A, Harrewyn JM (1989) Central analgesic effect of ketoprofen in humans: electrophysiologic evidence for a supraspinal mechanism in a double blind and crossover study. Pain 38: 1–7

    CAS  Google Scholar 

  • Willcox JC, Corr J, Shaw J, Richardson M, Calman KC, Drennan M (1984) Prednisolone as appetite stimulant in patients with cancer pain. Br Med J 288: 27

    Google Scholar 

  • World Health Organization (1996) Cancer pain relief,2nd edn.WHO, Geneva

    Google Scholar 

  • Yamada K, Ushio Y, Hayakawa T, Kato A, Arita N, Yamada N (1983) Effects of methylprednisolone on peritumoral brain edema.J Neurosurg 59: 612

    CAS  Google Scholar 

  • Zagon IS, Gibo DM, McLaughlin PI (1991) Zeta (),a growth-related opioid receptor in developing rat cerebellum: identification and characterization. Brain Res 551: 28–35

    PubMed  CAS  Google Scholar 

  • Zech DFJ, Grond S, Lynch J, Hertel D, Lehmann KA (1995) Validation of World Health Organization guidelines for cancer pain relief: a 10-year prospective study. Pain 63: 65–76

    PubMed  CAS  Google Scholar 

  • Zenz M (1993) Neues und Bewährtes in der medikamentösen Behandlung des chronischen Schmerzes.Schmerz [Suppl] 5: 52

    Google Scholar 

  • Zenz M, Willweber-Strumpf A (1993) Opiophobia and cancer pain in Europe. Lancet 341: 1075–1076

    PubMed  CAS  Google Scholar 

Download references

Authors
  1. B. Fazeny-Dörner
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. C. Dittrich
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2004 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Fazeny-Dörner, B., Dittrich, C. (2004). Medikamentöse Schmerztherapie in der Onkologie. In: Die Onkologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-06670-6_28

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-06670-6_28

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-06671-3

  • Online ISBN: 978-3-662-06670-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation